This report contains market size and forecasts of Neuromuscular Blocking Agent (NMBA) in global, including the following market information:
Global Neuromuscular Blocking Agent (NMBA) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Neuromuscular Blocking Agent (NMBA) Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Neuromuscular Blocking Agent (NMBA) companies in 2021 (%)
The global Neuromuscular Blocking Agent (NMBA) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Depolarizing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuromuscular Blocking Agent (NMBA) include AbbVie, GlaxoSmithKline, Pfizer, Hengrui Pharmaceutical, Abbott Laboratories, Fresenius Kabi, Sandoz, Somerset Therapeutics and Guike Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuromuscular Blocking Agent (NMBA) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuromuscular Blocking Agent (NMBA) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Neuromuscular Blocking Agent (NMBA) Market Segment Percentages, by Type, 2021 (%)
Depolarizing
Non-depolarizing
Global Neuromuscular Blocking Agent (NMBA) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Neuromuscular Blocking Agent (NMBA) Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Pharmacy
Others
Global Neuromuscular Blocking Agent (NMBA) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Neuromuscular Blocking Agent (NMBA) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuromuscular Blocking Agent (NMBA) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Neuromuscular Blocking Agent (NMBA) revenues share in global market, 2021 (%)
Key companies Neuromuscular Blocking Agent (NMBA) sales in global market, 2017-2022 (Estimated), (MT)
Key companies Neuromuscular Blocking Agent (NMBA) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
GlaxoSmithKline
Pfizer
Hengrui Pharmaceutical
Abbott Laboratories
Fresenius Kabi
Sandoz
Somerset Therapeutics
Guike Pharmaceutical
Shanghai Pharmaceuticals
Themis Medicare
Nanjing King-Friend